Increased serum interleukin-6 level and reduction of hepatic acute-phase response after major hepatectomy

European Surgical Research

Volumn 28, Issue 2, 1996, Pages 96-103

  Kimura, F ^a   Miyazaki, M ^b   Suwa, T ^a   Kakizaki, S ^a   Itoh, H ^b   Kaiho, T ^b   Nakajima, N ^b  

^a SAITAMA RED CROSS HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Acute phase proteins; Interleukin 6; Partial hepatectomy; Resectec liver volume

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HOST RESISTANCE; HUMAN; INFECTION RISK; LIVER LOBECTOMY; LIVER TUMOR; MALE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030024903     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129445     Document Type: Article

References (27)

1. Ekberg H, Tranberg KG, Anderson R. et al: Major liver resection: Perioperative course and management. Surgery 1986;100:1-8.
2. Sesto ME, Vogt DP, Hermann RE: Hepatic resection in 128 patients: A 24-ycar experience. Surgery 1987: 102:846-851.
3. Stimpson REJ, Pellegrini CA, Way LW: Factors affecting the morbidity of elective liver resection. Am J Surg 1987:153:189-196.
4. Yanaga K, Kanematsu T, Sagirnachi K, et al: Intrapcritoneal septic complications after hcpatectomy. Ann Surg 1986;203:148-152.
5. Yanaga K, Kanematsu T, Takenaka K, et al: Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988; 155:238-241.
6. Cole DJ, Ferguson CM: Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg 1992:58:88-91.
7. Arii S, Shibagaki M, Takahashi S. et al: Changes in the reticuloendothelial phagocytic function after partial hcpatectomy. J Lab Clin Med 1985: 105:668-672.
8. Milland J, Tsykin A, Thomas T. et al: Gene expression in regenerating and acutc-phase rat liver. Am J Physiol 1990:259:G340-G347.
9. Heinrich PC, Castell JV, Andus T: Interleukin-6 and the acute phase response. Biochem J 1990:265:621-636.
10. Schreiber G, Hewlett G: Synthesis and secretion of acutce-phase proteins: in G Lauman H. Peters T. Redman C (eds): Plasma protein secretion by the liver. London. Academic Press. 1983, pp 423-449.
11. Couinaud C: Lobes et segments hépatiques, notes sur l'architecture anatomique ct chirurgicale du l'oie. Presse Mcd 1954:62:709-712.
12. Murata A, Ogawa M, Yasuda T, et al: Scrum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoracoabdominal surgery. Immunol Invest 1990:19:271-278
13. Ohzato H, Yoshizaki K, Nishimoto N, et al: lnterleukin-6 as a new indicator of inflammatory status: Detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992:111:201-209.
14. Castell JV, Geiger T, Gross V, et al: Plasma clearance, organ distribution and target cells of interlcukin-6/hepatoevte-stimulating factor in the rat. Hur J Biochem 1988:177: 357-361.
15. Yamasaki K, TagaT, Hirata Y, et al: Cloning and expression of the human interlcukin-6 (BSF-2/INF(52) receptor. Science 1988:242:825-828.
16. Spanga G, Siegel JIL, Brown G. et al: Reprioritization of hepatic plasma protein release in trauma and sepsis. Arch Surg 1985:120:187-199.
17. Alcorn JM, Fierer J, Chojkier M: The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-«. Hepatology 1992:15: 122-129.
18. Warren HS, Chedid LA: Strategies for the treatment of endotoxemia: Significance of the acute-phase response. Rev Infect Dis 1987:9: S630-S638.
19. Tobias PS, McAdam WJ, Soldau K, et al: Control of lipopolysaccharide-high density lipoprotein interactions by an acute-phase reactant in human scrum. Infect Immun 1985:50: 73-76.
20. Tobias PS, Soldau K, Ulevitch RJ: Isolation of a lipopolysaccharide-binding acute phase reactant from rabbit serum. J Exp Med 1986:164: 777-793.
21. Freedman HH: Passive transfer of protection against lethality of homologous and heterologous endotoxins. Proc Soc Exp Biol Med 1959; 102:504-506.
22. Filkins JP: Blood endotoxin inactivation after trauma and endotoxioo-sis. Proc Soc Exp Biol Med 1976; 151:84-92.
23. 2-Maeroglobulin of the rat. an acute phase protein, mitigates the early course of endotoxin shock. Br J Exp Pathol 1986:67:313-319.
24. Waage A, Haistensen A, Espevik T: Association between tumor necrosis factor in scrum and fatal outcome in patients with meningococcal disease. Lancet 1987;i:355-357.
25. Curran RD, Billiar TR, Stuehr DJ, et al: Multiple cytokines arc required to induce hepatocyte nitric oxide production and inhibit total protein synthesis. Ann Surg 1990; 212:462-471.
26. Tracy KJ, Beutler B, Lowry SF, et al: Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470-474.
27. Rothstein JL, Schreiber H: Synergy between tumor necrosis factor and bacterial products causes hemorrhagic necrosis and lethal shock in normal mice. Proc Natl Acad Sei USA 1988:85:607-611.